1Schoser BG, Blottner D. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle. Neuroreport, 1999 ; 10(13): 2795.
2Singh A, Nelson-Moon ZL, Thomas G J, et al.Identification of matrix metalloproteinases and their tissue inhibitors type 1 and 2 in human masseter muscle. Arch Oral Biol,2000;45(6): 431.
3Guerin CW, Holland PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. Dev Dyn, 1995 ; 202 (1): 91.
4Sylvestre D, Balcerzak C, Feidt VE. et al. Elevated rate of collagen solubilization and postmortem degradation inmuscles of lambs with high growth rates: possible relationship with activity of matrix metalloproteinases. J Anim Sci,2002;80: 1871.
5Balcerzak D, Querengesser L, Dixon WT, et al.Coordinate expression of matrix-degrading proteinases and their activators and inhibkors in bovine skeletal muscle. J Anim Sci,2001 ;79(1) : 94.
6Kherif S, Lafuma C, Dehaupas M, et al. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol,1999;205(1) : 158.
7Kherif S, Dehaupas M, Lafuma C, et al. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve. Neuropathol Appl Neurobiol,1998;24(4): 309.
8Lo IK, Marchuk LL, Hollinshead R, et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med,2004;32(5) : 1223.
9Koskinen W, Wang A M, Ahtikoski M, et al. Acute exercise induced changes in rat skeletal muscle mRNAs and proteins regulating type Ⅳ collagen content. Am J Physiol Regul Integr Comp Physiol,2001;280(5): 208.
10Roach DM, Fitridge RA, Laws PE, et al. Upregulation of MMP-2 and MMP-9 leads to degradation of type Ⅳ collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg,2002;23(3): 260.
